Maxigen Biotech Inc (1783) — Cash Flow Quality Index
Maxigen Biotech Inc (1783) has a Cash Flow Quality Index of 1.51x as of March 2026. Operating cash flow of NT$79.84 Million exceeds net income of NT$52.79 Million, indicating high earnings quality where cash backs reported profits. Also explore 1783 current and non-current assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Maxigen Biotech Inc Cash Flow Quality Index (2009–2025)
Historical Cash Flow Quality Index for Maxigen Biotech Inc across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how tangible is Maxigen Biotech Inc's equity to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Maxigen Biotech Inc (2009–2025)
Year-by-year earnings quality comparison for Maxigen Biotech Inc. For live market cap and the full company financial profile, see how much is Maxigen Biotech Inc worth.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.95x | NT$290.22 Million | NT$304.89 Million | ▼ -28.0% |
| 2024 | 1.32x | NT$298.22 Million | NT$225.54 Million | ▲ +49.2% |
| 2023 | 0.89x | NT$171.20 Million | NT$193.14 Million | ▼ -45.2% |
| 2022 | 1.62x | NT$268.34 Million | NT$165.78 Million | ▲ +34.2% |
| 2021 | 1.21x | NT$117.59 Million | NT$97.47 Million | ▲ +24.4% |
| 2020 | 0.97x | NT$74.39 Million | NT$76.74 Million | ▼ -25.3% |
| 2019 | 1.30x | NT$94.42 Million | NT$72.80 Million | ▼ -56.4% |
| 2018 | 2.98x | NT$170.58 Million | NT$57.31 Million | ▲ +20.7% |
| 2017 | 2.47x | NT$41.18 Million | NT$16.70 Million | ▲ +137.7% |
| 2013 | -6.54x | NT$-22.34 Million | NT$3.42 Million | ▼ -203.2% |
| 2012 | 6.34x | NT$17.53 Million | NT$2.76 Million | ▲ +315.5% |
| 2009 | 1.53x | NT$19.27 Million | NT$12.63 Million | — |